AAAAAA
Results:
1-12
|
Results: 12
Authors:
SCHROHENLOHER RE
KOOPMAN WJ
WOODWORTH TG
MORELAND LW
Citation: Re. Schrohenloher et al., SUPPRESSION OF IN-VITRO IGM RHEUMATOID-FACTOR PRODUCTION BY DIPHTHERIA-TOXIN INTERLEUKIN-2 RECOMBINANT FUSION PROTEIN (DAB(486)IL-2) IN PATIENTS WITH REFRACTORY RHEUMATOID-ARTHRITIS, Journal of rheumatology, 23(11), 1996, pp. 1845-1848
Authors:
MILLER DD
BACH RG
TIO FO
BAILEY SR
WATERS CA
WOODWORTH TG
NICHOLS JC
PAIGE SB
FARRAR M
Citation: Dd. Miller et al., INTERLEUKIN-2 RECEPTOR-SPECIFIC FUSION TOXIN INHIBITS BAROTRAUMA-INDUCED ARTERIAL ATHEROSCLEROSIS, Atherosclerosis, 126(1), 1996, pp. 1-14
Authors:
GOTTLIEB SL
GILLEAUDEAU P
JOHNSON R
ESTES L
WOODWORTH TG
GOTTLIEB AB
KRUEGER JG
Citation: Sl. Gottlieb et al., RESPONSE OF PSORIASIS TO A LYMPHOCYTE-SELECTIVE TOXIN (DAB(389)IL-2) SUGGESTS A PRIMARY IMMUNE, BUT NOT KERATINOCYTE, PATHOGENIC BASIS, Nature medicine, 1(5), 1995, pp. 442-447
Authors:
MORELAND LW
SEWELL KL
TRENTHAM DE
BUCY RP
SULLIVAN WF
SCHROHENLOHER RE
SHMERLING RH
PARKER KC
SWARTZ WG
WOODWORTH TG
KOOPMAN WJ
Citation: Lw. Moreland et al., INTERLEUKIN-2 DIPHTHERIA FUSION PROTEIN (DAB(486)IL-2) IN REFRACTORY RHEUMATOID-ARTHRITIS - A DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL WITH OPEN-LABEL EXTENSION, Arthritis and rheumatism, 38(9), 1995, pp. 1177-1186
Authors:
PLATANIAS LC
RATAIN MJ
OBRIEN S
LARSON RA
VARDIMAN JW
SHAW JP
WILLIAMS SF
BARON JM
PARKER K
WOODWORTH TG
Citation: Lc. Platanias et al., PHASE-I TRIAL OF A GENETICALLY-ENGINEERED INTERLEUKIN-2 FUSION TOXIN (DAB(486)IL-2) AS A 6-HOUR INTRAVENOUS-INFUSION IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES, Leukemia & lymphoma, 14(3-4), 1994, pp. 257-262
Authors:
TEPLER I
SCHWARTZ G
PARKER K
CHARETTE J
KADIN ME
WOODWORTH TG
SCHNIPPER LE
Citation: I. Tepler et al., PHASE-I TRIAL OF AN INTERLEUKIN-2 FUSION TOXIN (DAB488IL-2) IN HEMATOLOGIC MALIGNANCIES - COMPLETE RESPONSE IN A PATIENT WITH HODGKINS-DISEASE REFRACTORY TO CHEMOTHERAPY, Cancer, 73(4), 1994, pp. 1276-1285
Authors:
MORELAND LW
SEWELL KL
SULLIVAN WF
SHMERLING RH
PARKER KC
SWARTZ WG
WOODWORTH TG
TRENTHAM DE
KOOPMAN WJ
Citation: Lw. Moreland et al., DOUBLE-BLIND PLACEBO-CONTROLLED PHASE-II TRIAL OF DIPHTHERIA-INTERLEUKIN-2 FUSION TOXIN (DAB486IL-2) IN PATIENTS WITH REFRACTORY RHEUMATOID-ARTHRITIS (RA), Arthritis and rheumatism, 36(9), 1993, pp. 190000039-190000039
Authors:
SCHROHENLOHER RE
KOOPMAN WJ
WOODWORTH TG
MORELAND LW
Citation: Re. Schrohenloher et al., SUPPRESSION OF IN-VITRO IGM AND IGM RHEUMATOID-FACTOR PRODUCTION BY DAB486IL-2 FUSION TOXIN THERAPY IN RHEUMATOID-ARTHRITIS (RA), Arthritis and rheumatism, 36(9), 1993, pp. 190000130-190000130
Authors:
SEWELL KL
MORELAND LW
CUSH JJ
FURST DE
WOODWORTH TG
MEEHAN RT
Citation: Kl. Sewell et al., PHASE-I II, DOUBLE-BLIND, DOSE-RESPONSE TRIAL OF 2ND FUSION TOXIN, DAB(389)IL-2, IN RHEUMATOID-ARTHRITIS/, Arthritis and rheumatism, 36(9), 1993, pp. 190000130-190000130
Authors:
SEWELL KL
PARKER KC
WOODWORTH TG
REUBEN J
SWARTZ W
TRENTHAM DE
Citation: Kl. Sewell et al., DAB(486)IL-2 FUSION TOXIN IN REFRACTORY RHEUMATOID-ARTHRITIS, Arthritis and rheumatism, 36(9), 1993, pp. 1223-1233
Authors:
MORELAND LW
SEWELL KL
SULLIVAN WF
SHMERLING RH
PARKER KC
SWARTZ WC
WOODWORTH TG
KOOPMAN WJ
TRENTHAM DE
Citation: Lw. Moreland et al., TREATMENT OF REFRACTORY RHEUMATOID-ARTHRITIS WITH DAB(486)IL-2 FUSIONTOXIN - DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY, Arthritis and rheumatism, 36(5), 1993, pp. 24-24
Authors:
SEWELL KL
MORELAND LW
SULLIVAN WF
SHMERLING RH
PARKER KC
SWARTZ WG
WOODWORTH TG
KOOPMAN WJ
TRENTHAM DE
Citation: Kl. Sewell et al., DAB(486)IL-2 IN RHEUMATOID-ARTHRITIS - A DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL WITH OPEN-LABEL CONTINUATION, Arthritis and rheumatism, 36(5), 1993, pp. 31-31
Risultati:
1-12
|